Literature DB >> 16564751

A role for Mlh3 in somatic hypermutation.

Ziqiang Li1, Jonathan U Peled, Chunfang Zhao, Anton Svetlanov, Diana Ronai, Paula E Cohen, Matthew D Scharff.   

Abstract

Somatic hypermutation (SHM) and class switch recombination (CSR) allow B cells to make high affinity antibodies of various isotypes. Both processes are initiated by activation-induced cytidine deaminase (AID) to generate dG:dU mismatches in the immunoglobulin genes that are resolved differently in SHM and CSR to introduce point mutations and recombination, respectively. The MutL homolog MLH3 has been implicated in meiosis and DNA mismatch repair (MMR). Since it interacts with MLH1, which plays a role in SHM and CSR, we examined these processes in Mlh3-deficient mice. Although deficiencies in other MMR proteins result in defects in SHM, Mlh3(-/-) mice exhibited an increased frequency of mutations in their immunoglobulin variable regions, compared to wild type littermates. Alterations of mutation spectra were observed in the Jh4 flanking region in Mlh3(-/-) mice. Nevertheless, Mlh3(-/-) mice were able to switch to IgG3 or IgG1 with similar frequencies to control mice. This is the first instance where a loss of a DNA repair protein has a positive impact on the rate of SHM, suggesting that Mlh3 normally inhibits the accumulation of mutations in SHM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564751     DOI: 10.1016/j.dnarep.2006.02.003

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  10 in total

Review 1.  DNA replication to aid somatic hypermutation.

Authors:  Zhenming Xu; Hong Zan; Zsuzsanna Pal; Paolo Casali
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

2.  I. VH gene transcription creates stabilized secondary structures for coordinated mutagenesis during somatic hypermutation.

Authors:  Barbara E Wright; Karen H Schmidt; Michael F Minnick; Nick Davis
Journal:  Mol Immunol       Date:  2008-06-27       Impact factor: 4.407

3.  The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair.

Authors:  J M M van Oers; Y Edwards; R Chahwan; W Zhang; C Smith; X Pechuan; S Schaetzlein; B Jin; Y Wang; A Bergman; M D Scharff; W Edelmann
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

4.  Evolution of coordinated mutagenesis and somatic hypermutation in VH5.

Authors:  Barbara E Wright; Karen H Schmidt; Aaron T Hunt; Dennis K Reschke; Michael F Minnick
Journal:  Mol Immunol       Date:  2011-11-05       Impact factor: 4.407

5.  Heat shock protein 70 (Hsp70)-stimulated deoxycytidine deaminases from a human lymphoma cell but not the activation-induced cytidine deaminase (AID) from Ramos 6.4 human Burkitt's lymphoma cells.

Authors:  Robert Bases
Journal:  Cell Stress Chaperones       Date:  2010-08-01       Impact factor: 3.667

Review 6.  Mismatch-mediated error prone repair at the immunoglobulin genes.

Authors:  Richard Chahwan; Winfried Edelmann; Matthew D Scharff; Sergio Roa
Journal:  Biomed Pharmacother       Date:  2011-10-24       Impact factor: 6.529

Review 7.  Identification of Candidate Predictors of Lupus Flare.

Authors:  Mary K Crow; Mikhail Olferiev; Kyriakos A Kirou
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

Review 8.  DNA mismatch repair: molecular mechanism, cancer, and ageing.

Authors:  Peggy Hsieh; Kazuhiko Yamane
Journal:  Mech Ageing Dev       Date:  2008-03-04       Impact factor: 5.432

9.  Alkyladenine DNA glycosylase (Aag) in somatic hypermutation and class switch recombination.

Authors:  Simonne Longerich; Lisiane Meira; Dharini Shah; Leona D Samson; Ursula Storb
Journal:  DNA Repair (Amst)       Date:  2007-08-06

10.  Mammalian Exo1 encodes both structural and catalytic functions that play distinct roles in essential biological processes.

Authors:  Sonja Schaetzlein; Richard Chahwan; Elena Avdievich; Sergio Roa; Kaichun Wei; Robert L Eoff; Rani S Sellers; Alan B Clark; Thomas A Kunkel; Matthew D Scharff; Winfried Edelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.